Unichem Laboratories Q2 FY27 consolidated PAT at Rs 22.22 cr
Unichem Laboratories’ consolidated Q2 FY27 revenue from operations was Rs 640.22 cr with PAT of Rs 22.22 cr versus a loss in Q2 FY26.
Key takeaways
- Revenue from operations for Q2 FY27 was Rs 640.22 cr vs Rs 578.96 cr a year earlier.
- Total income in Q2 FY27 rose to Rs 655.59 cr from Rs 599.93 cr in Q2 FY26.
- Profit / (Loss) after tax turned to Rs 22.22 cr from Rs (11.89) cr in Q2 FY26.
- Exceptional items expense was Rs 24.26 cr in Q2 FY27 vs Rs 58.26 cr in Q2 FY26.
- Basic EPS for Q2 FY27 was 3.16 compared with (1.69) in the corresponding quarter.
Q2 FY27 · consolidated
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 640.22 cr | Rs 578.96 cr | +10.6% |
| PAT | Rs 22.22 cr | Rs (11.89) cr | NA |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
- Net margin was 3.47% of revenue, up 552 bps from -2.05%.
- Revenue rose 10.6% while total expenses rose 9.3%.
- Cost of materials took 39.8% of revenue, against 33.3% a year earlier.
• Basis: Consolidated statement of unaudited financial results for the quarter ended 30.09.2026, compared with quarter ended 30.09.2025, as per the statement of financial results.
• Revenue from operations (Q2 FY27 vs Q2 FY26):
- Current quarter ended 30.09.2026: Rs 640.22 cr
- Corresponding quarter ended 30.09.2025: Rs 578.96 cr
• Other income:
- 30.09.2026: Rs 15.37 cr
- 30.09.2025: Rs 20.97 cr
• Total income (I+II):
- 30.09.2026: Rs 655.59 cr
- 30.09.2025: Rs 599.93 cr
• Cost of materials consumed:
- 30.09.2026: Rs 255.11 cr
- 30.09.2025: Rs 193.06 cr
• Purchase of stock-in-trade:
- 30.09.2026: Rs 68.17 cr
- 30.09.2025: Rs 39.76 cr
• Changes in inventories of stock-in-trade, finished goods and work-in-progress:
- 30.09.2026: Rs (52.79) cr
- 30.09.2025: Rs 37.56 cr
• Employee benefits expense:
- 30.09.2026: Rs 105.57 cr
- 30.09.2025: Rs 100.13 cr
• Finance costs:
- 30.09.2026: Rs 7.71 cr
- 30.09.2025: Rs 8.24 cr
• Depreciation and amortization expenses:
- 30.09.2026: Rs 30.49 cr
- 30.09.2025: Rs 31.47 cr
• Other expenses:
- 30.09.2026: Rs 189.70 cr
- 30.09.2025: Rs 142.27 cr
• Total expenses (IV):
- 30.09.2026: Rs 603.96 cr
- 30.09.2025: Rs 552.49 cr
• Profit / (Loss) before exceptional items and tax (VI):
- 30.09.2026: Rs 51.63 cr
- 30.09.2025: Rs 47.44 cr
• Exceptional items – expenses/(income):
- 30.09.2026: Rs 24.26 cr
- 30.09.2025: Rs 58.26 cr
• Profit / (Loss) before tax (VIII):
- 30.09.2026: Rs 27.37 cr
- 30.09.2025: Rs (10.82) cr
• Tax expense (total of current tax, deferred tax and earlier years):
- 30.09.2026: Rs 5.15 cr
- 30.09.2025: Rs 1.07 cr
• Profit / (Loss) for the period after tax (X):
- 30.09.2026: Rs 22.22 cr
- 30.09.2025: Rs (11.89) cr
• Total Comprehensive Income / (loss) for the period (XII):
- 30.09.2026: Rs 25.42 cr
- 30.09.2025: Rs (10.04) cr
• Paid-up equity share capital (Face value of Rs 2/- per share):
- 30.09.2026: Rs 14.08 cr
- 30.09.2025: Rs 14.08 cr
• Earnings per equity share (Face value of Rs 2/- per share) – Basic:
- 30.09.2026: 3.16
- 30.09.2025: (1.69)
• Earnings per equity share – Diluted:
- 30.09.2026: 3.14
- 30.09.2025: (1.69)
From the statement of financial results, consolidated revenue from operations for the quarter ended 30.09.2026 increased to Rs 640.22 cr from Rs 578.96 cr in the corresponding quarter of the previous year. Total income rose to Rs 655.59 cr from Rs 599.93 cr over the same period.
Total expenses moved up to Rs 603.96 cr in the quarter ended 30.09.2026 from Rs 552.49 cr a year earlier, with higher cost of materials consumed, purchase of stock-in-trade and other expenses. Profit / (Loss) before exceptional items and tax improved to Rs 51.63 cr from Rs 47.44 cr.
Exceptional items were an expense of Rs 24.26 cr in the quarter ended 30.09.2026 compared with an expense of Rs 58.26 cr in the quarter ended 30.09.2025. After exceptional items and tax, the company reported a profit for the period after tax of Rs 22.22 cr versus a loss of Rs (11.89) cr in the corresponding quarter. Basic earnings per share moved to 3.16 from (1.69), and diluted earnings per share moved to 3.14 from (1.69), on an unchanged equity share capital of Rs 14.08 cr.
Get Unichem Laboratories Ltd's next results the minute they're filed
Results reach the exchange at all hours, most of them after the market closes. Pro puts the filing in your feed as it is published, with our read of the numbers. A free account sees it an hourback for a day.
- We'll start you off following UNICHEMLAB.
- 14 days free, no card. After that you keep a free account.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.